Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY) is a multinational pharmaceutical company based in Hyderabad, India. The company was founded in 1984 and has
Categories
pharmaceuticals
Earnings Summary Of Jubilant Ingrevia Limited For Q3 FY23
Jubilant Ingrevia Limited (NSE: JUBLINGREA) is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the
Earnings Summary Of IPCA Laboratories Limited For Q3 FY23
Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription
Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry
Earnings Summary Of Indoco Remedies Limited For Q3 FY23
Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a
IPCA Laboratories Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:51] Kunal Dhamesha of Macquarie asked if IPCALAB is
Earnings Summary Of Glenmark Pharmaceuticals Limited For Q3 FY23
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) is a global research-driven pharmaceutical company that develops and markets innovative drugs for major therapeutic areas such
Earnings | Aurobindo Pharma Ltd. (NSE:AUROPHARMA): Q3FY23 Results Out; Total Income rise 7% YoY
Aurobindo Pharma Ltd. (NSE:AUROPHARMA) is a global pharmaceutical company headquartered in India. The company produces and sells a wide range of generic
Earnings | AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN): Q3FY23 Results Out; Total Income rise 25% YoY
AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN) is a leading biopharmaceutical company that operates in India. The company manufactures and markets prescription drugs for
Earnings Summary Of FDC Limited For Q3 FY23
FDC Limited (NSE: FDC) is a leading Indian pharmaceutical company that specializes in the manufacturing and marketing of a wide range of
Gufic Biosciences Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:06] Gunit Singh from CCIPL enquired about the driver
Earnings | Alkem Laboratories Ltd.(NSE:ALKEM): Q3FY23 Results Out; Total Income rise 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company based in India that specializes in the manufacturing and marketing of generic and branded drugs,
Earnings Summary Of GlaxoSmithKline Pharmaceuticals Limited For Q3 FY23
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is a leading pharmaceutical company in India that develops, manufactures, and markets a range of pharmaceutical products
Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY
Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company
Earnings|Abbott India Ltd (NSE:ABBOTTINDIA) : Q3FY23 Results Out; Total Income rise 10% YoY
Abbott India Ltd (NSE:ABBOTTINDIA) is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and is headquartered
SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri -- Executive Director Unidentified Speaker -- Analysts: Viraj
Earnings Summary Of Hikal Limited For Q3 FY23
Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing and manufacturing
IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Transcript
IPCA Laboratories Ltd (NSE:IPCALAB) Q3 FY23 Earnings Concall dated Feb. 16, 2023. Corporate Participants: Ajit Kumar Jain -- Joint Managing Director Harish Kamath -- Corporate Counsel
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Biocon Limited (BIOCON) Q3 FY23 Earnings Concall Transcript
Biocon Limited (NSE:BIOCON) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Saurabh Paliwal -- Head - Investor Relations Kiran Mazumdar Shaw -- Biocon Ltd.